Latest ADHD Stories
Aptensio XR to be available to patients in Summer 2015 COVENTRY, R.I., May 22, 2015 /PRNewswire/ -- Today, Rhodes Pharmaceuticals L.P.
The First, Once-Daily, Extended-Release Amphetamine-based Oral Liquid for the Treatment of ADHD MONMOUTH JUNCTION, N.J., May 21, 2015 /PRNewswire/ -- Tris Pharma, Inc.
LEXINGTON, Massachusetts, May 11, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that new research highlighting its commitment to the treatment
New Research findings, to be presented today at the international annual meeting of the Association for Research in Vision and Ophthalmology, show that GlassesOff technology can be used for early detection
The Claudia Black Young Adult Center introduces test that screens, diagnoses and monitors attention disorders such as ADHD. Wickenburg, Arizona (PRWEB) April
LEXINGTON, Massachusetts, April 7, 2015 /PRNewswire/ -- - Potential Launch of SHP465 Anticipated in Second Half of 2017 - Exclusivity for Shire's
LONDON, April 1, 2015 /PRNewswire/ -- ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary
ATLANTA, April 1, 2015 /PRNewswire-USNewswire/ -- The first national study to look at behavioral therapy, medication, and dietary supplements to treat attention-deficit/hyperactivity disorder
OTTAWA, March 30, 2015 /CNW/ - Stronger, clearer warnings on the risk of suicidal thoughts and behaviours are being incorporated into the prescribing information for drugs used in the management
BOULDER, Col., March 6, 2015 /PRNewswire/ -- NEBA Health announces today that Brain and Behavior has published validation results for the first biomarker cleared by FDA to assist a
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.